A Long-term Efficacy and Safety of NTQ5082 Capsules

Clinical trial NCT07177872 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07177872
Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria

Start date: 2026-06-01
Primary completion: 2028-06-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.